ArticleBMC pregnancy and childbirth2025
Evaluating the application and clinical practice of adapted national preeclampsia and eclampsia guideline; a cross-sectional study from Iran.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertensive disorders during pregnancy (HDP) are a significant cause of maternal mortality. The present study examined the extent of preeclampsia and eclampsia guideline use across different healthcare provider groups, aiming to provide evidence-based recommendations for better guideline implementation.
methodsA cross-sectional study was conducted from 2021-10-04 to 2022-04-04. Participants were maternal health providers from 63 medical universities in the country. For evaluating clinical applicability of the guideline, an online questionnaire developed. Questionnaire was designed to evaluate the Implementation, Usability, Validity, Applicability, Accommodation, and Evaluation of national guideline. The mean score for each question was calculated and categorized in unfavorable, relatively favorable, and favorable values. The online questionnaire was delivered to the all-guideline users. The answered questionnaires were sent back to the research team after a week.
resultsTotally, 1,283 health care providers as the respondents completed the questionnaires. The ways to access the guideline that were expressed by the participants were: printed book in 57.9%, medical websites in 11.2%, CDs in 10.5%, and posters, bulletins, and brochures in 20.4%. The results delineated that general practitioner had the highest scores related to the majority of domains consisting of Implementation, Usability, Evaluation, and Validity than Behvarz (community health workers in the rural and urban healthcare centers), midwife, and obstetrician groups (p < 0.01). The results showed that mother's non-compliance, non-practical content of guideline, and lack of facilities were the most important reported challenges in guideline implementation.
conclusionTo effectively enhance the national preeclampsia guideline, it is critical to adopt a structured approach based on feedback from diverse healthcare providers. Key areas identified for improvement include ensuring comprehensive guideline awareness through better distribution, enhancing usability by simplifying language and offering quick-reference tools, regularly updating the guideline with new research, adapting it for varied clinical environments, accommodating the specific needs of different provider groups, and establishing a continuous evaluation mechanism through feedback loops. These steps aim to refine the guideline's practicality, reliability, and comprehensiveness in managing preeclampsia across diverse healthcare settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.